IPO floodgates open up after summer lull as five more biotechs file for Nasdaq

It’s once again open season for biotech IPOs, as the summer drought has given way to an autumn flood.

Five companies filed to go public on Friday, including four penciling in $100 million fundraises: Evotec, Entrada Therapeutics, Aura Biosciences and Vaxxinity. The fifth biotech, Blue Water Vaccines, is estimating a more modest $24 million.